Frailty and long-term outcomes in younger patients with acute myocardial infarction. Read more in the @EHJ at https://t.co/zgO3vNa1HO #AcuteMyocardialInfarction #Frailty #LongTermOutcomes @ESCardio @ESC_journals

Atherosclerosis is a chronic inflammatory disease of the arterial wall. New study reveals that enhanced antigen presentation by macrophages activates local T-cell inflammatory response. https://t.co/n9iJ46ObqE #atherosclerosis #inflammation #cardiotwitter, @ESC_Journals,

One month left! Share your research with the global cardiovascular community at #EASCongress2026, 24–27 May 2026 in Athens. Be part of the dialogue shaping the future of atherosclerosis research. 📅 Deadline: 3 Dec 2025 🔗 https://t.co/U8P3Mk6RTo #Atherosclerosis

Cardiovascular biomarkers for risk stratification in primary prevention. Read this State-of-the-Art review in #EHJ 👉 https://t.co/aOKqJc8ilT @RoccoMontone @ehj_ed

1 in 3 cancer patients may experience serious cardiovascular side effects from treatment. For the first time, experts from cardiology, oncology, haematology, radiology, nursing and more are meeting under one roof at #ESCardioOnco2025 United by a shared mission to improve care

AI-driven body tissue segmentation to analyze CT scans, revealing key correlations and outcome associations. A step toward personalized risk stratification. Read more in #EHJ. https://t.co/vUdiSjdRac #ACC2025 #cardiotwitter @ESC_Journals @escardio

The role of low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) in cardiovascular risk assessment for early intervention. Read more about the EPIC-Norfolk study in #EHJ. https://t.co/wUsPMmfy3V #atherosclerosis #cardiotwitter @ESC_Journals @escardio

Lipid lowering therapy and sustained weight management: a winning combination in patients with heterozygous familial hypercholesterolaemia! https://t.co/468TzNqj7U #cholesterol #lipid #lowering #obesity #EHJ #cardiotwitter @ESC_journals @escardio

Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study. Read more in #EHJ https://t.co/Le5S3frmp9 #HeartFailure #ArtificialIntelligence #ECG #MachineLearning @ESCardio @ESC_Journals

Functional assessment of coronary artery disease in patients with severe aortic stenosis: a review https://t.co/hZmQqi54fW

Only two weeks left to register at regular rates for #EASCongress2025. Don’t wait any longer - secure your spot in Glasgow! 👉 https://t.co/04vFQWQrTA #CardiovascularHealth #Cardiovascular #AtherosclerosisResearch #HeartHealthExperts

Our heart disease infographics are now in multiple European languages! 🌍🫀 They cover risk factors & the use of AI + multiomics in heart disease research. Check them out & share! 🔗 https://t.co/VPKcT2P8dL #HeartHealth #AI #Multiomics #AtheroNET

#ANOCA versus obstructive CAD – a comparison between pre- and post-angiography clinical characteristics, management and outcomes. More in https://t.co/whJnIDrbcW #EHJQCCO #CVD #@cpgale3 @diogoasantosfer @m_piepoli

The year in cardiovascular medicine 2024: the top 10 papers in thrombosis and antithrombotic treatment. Read more in #EHJ! @escardio @ESC_Journals #thrombosis https://t.co/SvD1JqjhLc

https://t.co/Fb6WAUuiq9

Handle with care, proceed with caution: do frail patients presenting with acute coronary syndrome benefit from revascularization? Read more in #EHJ: https://t.co/0c6iYpdCLO @escardio @ESC_Journals

🎉 Commissioner for Health and Animal Welfare Mr Olivér Várhelyi announces that the European Commission will develop a new European Cardiovascular Health Plan ⤵️ 📽️ The success and impact of a European CVH Plan will depend not only on what is achieved in the next few years but

Handle with care, proceed with caution: do frail patients presenting with acute coronary syndrome benefit from revascularization? Read more in EHJ. @ESCardio @ESC_Journals #frailty #ACS #revascularization

The optimal revascularization strategy in patients with ischaemic cardiomyopathy remains unclear. New large registry study investigates long-term survival in patients with severe ischaemic cardiomyopathy revascularized by #CABG / #PCI #CAD #cardiotwitter, @ESC_Journals, @escardio

GLP-1 receptor agonists are revolutionizing obesity treatment but can cause significant muscle loss. ​ Balancing weight loss with muscle preservation is crucial for overall health. ​ Future research and strategic approaches, including nutrition and exercise, are essential.